Cargando…
Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study
PURPOSE: Ulinastatin, a serine protease inhibitor, inhibits several pro-inflammatory proteases and decreases inflammatory cytokine levels and mortality in experimental sepsis. We studied the effect of ulinastatin on 28-day all-cause mortality in a double-blind trial in patients with severe sepsis in...
Autores principales: | Karnad, Dilip R., Bhadade, Rakesh, Verma, Pradeep K., Moulick, Nivedita D., Daga, Mradul K., Chafekar, Neelima D., Iyer, Shivakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028549/ https://www.ncbi.nlm.nih.gov/pubmed/24737258 http://dx.doi.org/10.1007/s00134-014-3278-8 |
Ejemplares similares
-
Effect of Urinary Trypsin Inhibitor (Ulinastatin) Therapy in COVID-19
por: Jain, Ashish, et al.
Publicado: (2022) -
Beneficial effects of ulinastatin on gut barrier function in sepsis
por: Jiang, Longyuan, et al.
Publicado: (2013) -
Protective effect of rhubarb combined with ulinastatin for patients with sepsis
por: Meng, Fulei, et al.
Publicado: (2020) -
A retrospective study of ulinastatin for the treatment of severe sepsis
por: Meng, Chao, et al.
Publicado: (2020) -
The effect of ulinastatin on sepsis in the rats of adhesion molecules and endothelial function
por: Hao, X, et al.
Publicado: (2015)